Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 5Nausea 4Neoplasms 3Lymphoma 2Colonic Neoplasms 2Solid Tumors 1Prostatic Neoplasms 1Polyps 1Mouth Neoplasms 1Metastatic Neuroendocrine Prostate Cancer 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Intestinal Obstruction 1Hypopharyngeal Neoplasms 1Critical Illness 1Breast Neoplasms 1

Interventions

Octreotide 3lanreotide 1Rocuronium 1Quality of Life 1Propofol 1Paclitaxel 1Nicotine 1Naloxone 1Metoclopramide 1Methylprednisolone 1Gastric Bypass 1Food, Formulated 1Diet Therapy 1Dexmedetomidine 1Dexamethasone 1Cisplatin 1Anastomosis, Roux-en-Y 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Obstruction × Metoclopramide × Clear all
NCT04027348 2022-11-29

Palliative Management of Inoperable Malignant Bowel Obstruction

Roswell Park Cancer Institute

Phase 2 Terminated
15 enrolled 10 charts

Intestinal Obstruction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡